Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression-Reference-Cited by-同舟云学术

Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression

Published:2018-02-23 Issue:4 Volume:7 Page:1297-1316
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Huang Meixian¹,Inukai Takeshi¹^ORCID,Miyake Kunio²,Tanaka Yoichi³,Kagami Keiko¹,Abe Masako¹,Goto Hiroaki⁴,Minegishi Masayoshi⁵,Iwamoto Shotaro⁶,Sugihara Eiji⁷,Watanabe Atsushi¹,Somazu Shinpei¹,Shinohara Tamao¹,Oshiro Hiroko¹,Akahane Koshi¹,Goi Kumiko¹,Sugita Kanji¹

Affiliation:

1. Department of Pediatrics; School of Medicine; University of Yamanashi; Yamanashi Japan

2. Department of Health Sciences; School of Medicine; University of Yamanashi; Yamanashi Japan

3. Department of Clinical Pharmacy; School of Pharmacy; Kitasato University; Tokyo Japan

4. Hematology/Oncology and Regenerative Medicine; Kanagawa Children's Medical Center; Yokohama Japan

5. Japanese Red Cross Fukushima Blood Center; Fukushima Japan

6. Department of Pediatrics; Mie University Graduate School of Medicine; Tsu Japan

7. Division of Gene Regulation; Institute for Advanced Medical Research; School of Medicine; Keio University; Tokyo Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1323/fullpdf

Reference34 articles.

1. Genetic factors influencing cytarabine therapy;Lamba;Pharmacogenomics,2009

2. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562;Dumontet;Br. J. Haematol.,1999

3. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity;Stegmann;Blood,1995

4. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine;Galmarini;Br. J. Haematol.,2003

5. Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia;Stammler;Anticancer Drugs,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications;Frontiers in Pharmacology;2023-12-07

2. CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer;European Journal of Cell Biology;2023-06

3. Understanding and targeting resistance mechanisms in cancer;MedComm;2023-05-22

4. Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?;European Journal of Drug Metabolism and Pharmacokinetics;2022-08-01

5. Clofarabine increases the eradication of minimal residual disease of primary Bprecursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome;Haematologica;2021-08-05